Fraser Claire — SEC Form 4 filings
SEC reporting owner CIK 1382031. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-25 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 1,780 shares, $337,892 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 917 shares @ $187.50 ($171,938) in BECTON DICKINSON & CO, filed 2025-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | Director | 4 | — | 2 legs · 1,780 sh · $337,892 | 2 |
| Seres Therapeutics, Inc. (MCRB) | Director | 4 | — | — | 4 |
| WATERS CORP /DE/ (WAT) | Director | 1 | — | — | 2 |
Form 4 filings — Fraser Claire
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 358 @ $0 · Grant/award (A): 877 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | BECTON DICKINSON & CO (BDX) | Sale (S): 917 @ $187.50 | EDGAR |
| 2025-08-08 | 4 | BECTON DICKINSON & CO (BDX) | Sale (S): 863 @ $192.30 | EDGAR |
| 2025-07-02 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 6,452 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | BECTON DICKINSON & CO (BDX) | Grant/award (A): 930 @ $0 | EDGAR |
| 2024-04-08 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | BECTON DICKINSON & CO (BDX) | Grant/award (A): 900 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1382031 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →